DiabetesSisters kicks off campaign aimed at diabetic women
RALEIGH, N.C. A nonprofit that seeks to improve the health and quality of life of women with — and those at risk of developing — diabetes has kicked off a national campaign.
DiabetesSisters said that its OrangeWill campaign represents the will and determination required for women to manage their diabetes on top of their many other responsibilities.
"For far too long women with diabetes have been overlooked and divided into separate groups based on the type of diabetes they have. Now is the time for us to come together and make our voice heard," said Brandy Barnes, founder and CEO of DiabetesSisters.
More information can be found at Orangewill.org.
Hyland’s looks to have reformulated teething tablets back on the market in 2011
LOS ANGELES Hyland’s plans to have a reformulated Teething Tablets product back on the market in early 2011, the company stated, following the initiation of its voluntary recall of the product last week.
Consumer reaction to the recall overall has been supportive, Jay Borneman, Hyland’s chairman and CEO, told Drug Store News. “Our Facebook friends went up by half; the blog posts were almost three-to-one positive,” he said. From this point, Borneman said, Hyland’s will be looking to introduce an improved product offering, instituting new production protocols to ensure the consistency behind what will be a reformulated Teething Tablets product, along with incorporating child-resistant packaging.
Hyland’s experience also may serve as a case example of how to efficiently execute a recall for mid-tier companies. This marked the first product recall in Hyland’s history, Borneman said, requiring the company to acquire and put into action entirely new skill sets — such as reverse logistics, for example. “For us to react to what we had decided to do, frankly, required us in very short measure to build some fairly sophisticated competencies,” he said. “Over the course of the last couple of years, our friends over at [the Consumer Healthcare Products Association] had introduced us to a large number of people who became very important very fast in the course of managing the project,” Borneman added, enabling the company to effectively execute against its decision to recall the products.
Hyland’s recalled its Hyland’s Teething Tablets on Oct. 23 “in an abundance of caution due to an FDA investigation of its manufacturing facility,” the company stated. The company, in working with the FDA, has identified manufacturing processes of Teething Tablets that can be improved to ensure uniformity in dosage.
Adverse events have been reported, but the FDA said that a conclusive link had not been determined.
Wegmans introduces co-branded glucose monitoring system with Nipro
ROCHESTER, N.Y. Wegmans on Monday announced the availability of its co-branded blood-glucose monitoring systems: Nipro Diagnostics’ TrueResult system and True2go.
“Glucose self-monitoring, along with carbohydrate-counting, helps people with diabetes develop an everyday pattern with the best amounts and timing for food, exercise and insulin,” stated Wegmans nutrition and product labeling manager Jane Andrews. “Later on, they can use testing information to make adjustments. For example, they might check blood glucose levels just before going out for a 30-minute run, and results will help them decide how much extra carbohydrate to eat so that blood sugars don’t drop too low. "
Testing is key to staying on track, added Wegmans pharmacist Brian Pompo, coordinator of wellness and clinical services for pharmacy. “Your daily measures of blood glucose let you know if you have your diabetes under control, and give your healthcare providers the data they need to make therapy decisions.”